Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Yun-Jiang Liu · SciRah

Researcher profile · Semantic Scholar

Yun-Jiang Liu

Share profile

Yun-Jiang Liu — researcher profile on SciRah

h-index: 25
Works: 166
Citations: 2,460

Most-cited papers

Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer: a randomized, phase 3 trial
Bing-He Xu, Qing-Yuan Zhang, Pin Zhang, Xi-Chun Hu +22 more
2021Nature Medicine161 citations
Semantic Scholar
Engineering CAR-NK cell derived exosome disguised nano-bombs for enhanced HER2 positive breast cancer brain metastasis therapy.
Bo-Long Tao, Ruo-Xin Du, Xiang-Mei Zhang, Bo Jia +3 more
2023Journal of Controlled Release134 citations
Semantic Scholar
PDPN positive CAFs contribute to HER2 positive breast cancer resistance to trastuzumab by inhibiting antibody-dependent NK cell-mediated cytotoxicity.
Ruo-Xin Du, Xiang-Mei Zhang, Xi-Yan Lu, Xiang-Min Ma +7 more
2023Drug resistance updates95 citations
Semantic Scholar
RC48-ADC, a HER2-targeting antibody-drug conjugate, in patients with HER2-positive and HER2-low expressing advanced or metastatic breast cancer: A pooled analysis of two studies.
Jia-Yu Wang, Yun-Jiang Liu, Qing-Yuan Zhang, Ji-Feng Feng +14 more
202191 citations
Semantic Scholar
Neoadjuvant pyrotinib, trastuzumab, and docetaxel for HER2-positive breast cancer (PHEDRA): a double-blind, randomized phase 3 trial
Jiong Wu, Zefei Jiang, Zhen-Zhen Liu, Ben-long Yang +18 more
2022BMC Medicine73 citations Open access
Semantic Scholar
Camrelizumab vs Placebo in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-Negative Breast Cancer: The CamRelief Randomized Clinical Trial.
Li Chen, Hui Li, Hao Zhang, Hua Yang +31 more
2024Journal of the American Medical Association (JAMA)63 citations Open access
Semantic Scholar
Disitamab vedotin, a HER2‐directed antibody‐drug conjugate, in patients with HER2‐overexpression and HER2‐low advanced breast cancer: a phase I/Ib study
Jia-Yu Wang, Yun-Jiang Liu, Qing-Yuan Zhang, Wei Li +5 more
2024Cancer Communications56 citations Open access
Semantic Scholar
CACA Guidelines for Holistic Integrative Management of Breast Cancer
Jiong Wu, Dai-Ming Fan, Zhi-Min Shao, Bing-He Xu +137 more
2022Holistic Integrative Oncology54 citations Open access
Semantic Scholar
Doxorubicin resistance in breast cancer is mediated via the activation of FABP5/PPARγ and CaMKII signaling pathway
Nan-Nan Chen, Xin-di Ma, Zhuang Miao, Xiang-Mei Zhang +6 more
2023Frontiers in Pharmacology42 citations Open access
Semantic Scholar
The Diagnostic Value of Serum Exosomal Has_circ_0000615 for Breast Cancer Patients
Jia-Ni Liu, Xin-Yu Peng, Yin-Feng Liu, R. Hao +6 more
2021International Journal of General Medicine24 citations Open access
Semantic Scholar
Expression of BCRP/ABCG2 Protein in Invasive Breast Cancer and Response to Neoadjuvant Chemotherapy
Yan-Shou Zhang, Chao Yang, Lei Han, Lei Liu +1 more
2021Oncology Research and Treatment23 citations
Semantic Scholar
HER2-targeting antibody drug conjugate FS-1502 in HER2-expressing metastatic breast cancer: a phase 1a/1b trial
Qiao Li, Ying Cheng, Z. Tong, Yun-Jiang Liu +17 more
2024Nature Communications21 citations Open access
Semantic Scholar
The prognostic role of lymph node ratio in breast cancer patients received neoadjuvant chemotherapy: A dose-response meta-analysis
Jin-Zhao Liu, Yifei Li, Weifang Zhang, Chen-Hui Yang +7 more
2022Frontiers in Surgery21 citations Open access
Semantic Scholar
Exosome miR‐134‐5p restrains breast cancer progression via regulating PI3K/AKT pathway by targeting ARHGAP1
Chao Yang, Geng Zhang, Yan-Shou Zhang, Shuo Zhang +2 more
2021The journal of obstetrics and gynaecology research20 citations
Semantic Scholar
Metastasis patterns and prognosis in young breast cancer patients: A SEER database analysis
Weifang Zhang, S. Wu, Jin-Zhao Liu, Xiang-Mei Zhang +5 more
2022Frontiers in Oncology16 citations Open access
Semantic Scholar
The expression landscape of FOXP3 and its prognostic value in breast cancer
Jing-Ping Li, Xiang-Mei Zhang, Beichen Liu, C. Shi +4 more
2022Annals of Translational Medicine13 citations Open access
Semantic Scholar
Prognostic and immunological value of ATP6AP1 in breast cancer: implications for SARS-CoV-2
Jintian Wang, Yun-Jiang Liu, Shuo Zhang
2021Aging13 citations Open access
Semantic Scholar
Axillary lymph node dissection in triple-negative or HER2-positive breast cancer patients with clinical N2 achieving pathological complete response after neoadjuvant therapy: Is it necessary?
Xu-Hui Guo, Jiao Zhang, Xi-Long Gong, Jia Wang +23 more
2024Breast12 citations Open access
Semantic Scholar
An integrative analysis of ASCL1 in breast cancer and inhibition of ASCL1 increases paclitaxel sensitivity by activating ferroptosis via the CREB1/GPX4 axis
Xiao-Lu Yang, Yilu Li, Yaqi Peng, Yuan Chang +8 more
2025Frontiers in Immunology11 citations
Semantic Scholar
Circ_0,007,331 Promotes the PTX Resistance and Progression of Breast Cancer via miR-200b-3p/ANLN.
Chao Yang, Liang Liu, Chao Gao, Geng Zhang +4 more
2022Journal of Surgical Research10 citations Open access
Semantic Scholar
Cost-effectiveness evaluation of risk-based breast cancer screening in Urban Hebei Province
Jin Shi, Y. Guan, D. Liang, Dao-Juan Li +2 more
2023Scientific Reports9 citations Open access
Semantic Scholar
NRBP1 negatively regulates SALL4 to reduce the invasion and migration, promote apoptosis and increase the sensitivity to chemotherapy drugs of breast cancer cells
Chao Yang, Xiang-Mei Zhang, Chao Gao, Kaiye Du +1 more
2022Oncology Letters9 citations Open access
Semantic Scholar
Real-world study of trastuzumab and pertuzumab combined with chemotherapy in neoadjuvant treatment for patients with HER2-positive breast cancer
Xiangming Ma, Xiang-Mei Zhang, Xiaoping Zhou, Xiao-Fei Ren +5 more
2022Medicine9 citations Open access
Semantic Scholar
The beneficial role of Asian-based RecurIndex test in the prognostic prediction in Chinese male breast cancer patients
Shuo Zhang, Beichen Liu, Mengli Zhou, Jintian Wang +11 more
2021Scientific Reports9 citations Open access
Semantic Scholar
Novel CDK2/4/6 inhibitor culmerciclib (TQB3616) plus fulvestrant in previously treated, HR-positive, HER2-negative advanced breast cancer: a randomized, double-blind, phase 3 trial
Yong-Mei Yin, Qing-Yuan Zhang, T. Sun, Chun-Fang Hao +53 more
2025Signal Transduction and Targeted Therapy8 citations
Semantic Scholar
Knockdown of NDUFAF6 inhibits breast cancer progression via promoting mitophagy and apoptosis
Shang Wu, Xin-Di Ma, Xiang-Mei Zhang, Kaiye Du +5 more
2024Cancer Biology & Therapy8 citations Open access
Semantic Scholar
Identification of molecular subtypes based on chromatin regulator-related genes and experimental verification of the role of ASCL1 in conferring chemotherapy resistance to breast cancer
Yilu Li, Xiao-Lu Yang, Cui-Zhi Geng, Yun-Jiang Liu +6 more
2024Frontiers in Immunology8 citations Open access
Semantic Scholar
Comprehensive Analysis of the Expression and Prognostic Significance of the CENP Family in Breast Cancer
Xue-Liang Liu, Yun-Jiang Liu
2022International Journal of General Medicine8 citations Open access
Semantic Scholar
MIR-518a-5p Targets ZEB2 to Suppress the Migration and Invasion of Breast-cancer Cells.
Li Wang, Ziru Guo, Shuo Zhang, Xiao-Chong Zhang +3 more
2022Alternative Therapies in Health and Medicine8 citations
Semantic Scholar
Hsa_circ_0002496 promotes the growth, angiogenesis, and stemness of breast cancer cells via miR‐433‐3p/YWHAZ cascade
Chao Yang, Shuo Zhang, Liang Liu, Xiang-Mei Zhang +4 more
2023Thoracic Cancer7 citations Open access
Semantic Scholar
Abstract PD8-08: Pyrotinib in combination with trastuzumab and docetaxel as neoadjuvant treatment for HER2-positive early or locally advanced breast cancer (PHEDRA): A randomized, double-blind, multicenter, phase 3 study
Jiong Wu, Zhen-Zhen Liu, Hong-Jian Yang, Jin-Hai Tang +17 more
2022Cancer Research7 citations
Semantic Scholar
Artesunate regulates malignant progression of breast cancer cells via lncRNA TUG1/miR-145-5p/HOXA5 axis
Chao Yang, Yun-Jiang Liu, Li-Gang Gai, Zi-Teng Zhang +4 more
2025PLoS ONE6 citations Open access
Semantic Scholar
Dalpiciclib (Dalp) plus endocrine therapy (ET) as adjuvant treatment for HR+/HER2– early breast cancer (BC): The randomized, phase 3, DAWNA-A trial.
Z. Shao, Ji-Hui Hao, Shui Wang, Qing-Yuan Zhang +16 more
2025Journal of Clinical Oncology6 citations Open access
Semantic Scholar
Circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers combined with clinicopathological risk has potential to better predict recurrence in stage III breast cancer treated with neoadjuvant chemotherapy: a pilot study
Kai-Ye Du, Shang Wu, Xin-Di Ma, Yun-Jiang Liu
2024Breast Cancer Research and Treatment6 citations
Semantic Scholar
A large single-center prospective study to investigate the factors influencing the choice of breast-conserving surgery versus mastectomy in Chinese women with early breast cancer
Zhen-Sheng Li, Yun-Jiang Liu, Jing Zhang, Yue Li +4 more
2023World Journal of Surgical Oncology6 citations Open access
Semantic Scholar
Blocking the Notch signal transduction pathway promotes tumor growth in breast cancer by promoting the expression of suppressible inflammatory factors
Shuguang Ren, Yueyang Hu, Y. Ju, Yang Sang +6 more
2022Annals of Translational Medicine6 citations Open access
Semantic Scholar
Folate Receptor 4-Expressing T cell Is Associated with Disease-Free Survival in Patients with Esophageal Squamous Cell Carcinoma
Xiang-Mei Zhang, Qi Zhao, M. Cao, Xinhui Li +4 more
2022Disease Markers6 citations Open access
Semantic Scholar
The value of hsa_circ_0058514 in plasma extracellular vesicles for breast cancer
Jia-Ni Liu, Xinyu Peng, Yang Yang, Yao-Jun Zhang +10 more
2022Frontiers in Oncology6 citations Open access
Semantic Scholar
Clinical practice guidelines for breast cancer implantable intravenous infusion ports: Chinese Society of Breast Surgery practice guidelines 2021
Li Ma, Zhicheng Ge, L. Xin, Ying-Xin Wang +7 more
2021Chinese Medical Journal6 citations Open access
Semantic Scholar
Apatinib Combined with Paclitaxel and Cisplatin Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
Ji-Dong Zhao, Ming He, Jie Li, Dan Li +6 more
2021Cancer Biotherapy and Radiopharmaceuticals6 citations
Semantic Scholar
Tumor-expressing PD-L1 regulates NT5E expression through MAPK/ERK pathway in triple-negative breast cancer
Chen Cheng, Chao Shi, Shang Wu, Wei-Xin Wu +6 more
2025Oncology Research5 citations Open access
Semantic Scholar
Association of a complete breast cancer pathologic response with axillary lymph node metastasis via neoadjuvant chemotherapy: Results from the CSBrS-012 study
Lessler Ma, P. Gao, Zhen-Zhen Liu, De-Chuang Jiao +31 more
2023Chinese Medical Journal5 citations Open access
Semantic Scholar
Changes in HER2 status and survival outcomes in patients with non-pathological complete response after neoadjuvant targeted treatment
Xiao-Fei Ren, Xiang-Mei Zhang, Xiang-Min Ma, Chao Yang +4 more
2023Medicine5 citations Open access
Semantic Scholar
Health prevention intervention for chronic tissue fibrosis: Based on the specific expression of CCL19/21 + mast cell.
Xiang-Mei Zhang, Ji-Dong Zhao, Beichen Liu, Shuguang Ren +4 more
2023Preventive Medicine5 citations Open access
Semantic Scholar
Clinical practice guidelines for the diagnosis and treatment of inflammatory breast cancer: Chinese Society of Breast Surgery (CSBrS) Practice Guidelines 2022
Li Ma, Yan-Shou Zhang, Tian-Tian Tang, Xiang-Mei Zhang +1 more
2023Chinese Medical Journal4 citations Open access
Semantic Scholar
Abstract P4-01-07: FS-1502, an anti-HER2 ADC, in Patients with HER2-Expressing Advanced Solid Tumors: A Phase 1a Dose-Escalation Study
Qiao Li, Xian Wang, Ying Cheng, Yun-Jiang Liu +12 more
2023Cancer Research4 citations
Semantic Scholar
Comprehensive analysis of PTPN13 expression and its clinical implication in breast cancer.
Jing-Ping Li, Xiang-Mei Zhang, Bei-chen Liu, Shuguang Ren +2 more
2023Neoplasma (Bratislava)4 citations Open access
Semantic Scholar
Efficacy analysis of neoadjuvant chemotherapy with or without anthracyclines in female patients with HER2-positive breast cancer in China: a nationwide, multicenter, 10-year retrospective study (CSBrS-012)
Heyan Chen, Amina Maimaitiaili, Zhen-Zhen Liu, R. Ling +20 more
2023Therapeutic Advances in Medical Oncology4 citations Open access
Semantic Scholar
Adjuvant tamoxifen switched to exemestane treatment in postmenopausal women with estrogen receptor-positive early breast cancer: A pragmatic, multicenter, and prospective clinical trial in China.
Bing-He Xu, Hui-Ping Li, Zefei Jiang, L. Gu +10 more
2022Chinese journal of cancer research = Chung-kuo yen cheng yen chiu4 citations Open access
Semantic Scholar
Fear of Cancer Recurrence Contributes Largely to Patient Anxiety and Depression and Quality of Life in a Prospective Cohort of Chinese Breast Cancer Patients for Postoperative Radiotherapy
Zhen-Sheng Li, Yun-Jiang Liu, Yue Li, Y. Shang +6 more
2025The Breast Journal3 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Xiang-Mei Zhang×17
Invite
Xiang-Mei Zhang — researcher profile on SciRah
Chao Yang×8
Invite
Chao Yang — researcher profile on SciRah
Shuo Zhang×8
Invite
Shuo Zhang — researcher profile on SciRah
Xin-Di Ma×7
Invite
Xin-Di Ma — researcher profile on SciRah

×7

Invite

Jing-Ping Li — researcher profile on SciRah

Invite

Bing-He Xu — researcher profile on SciRah

Yan-Shou Zhang×6

Invite

Yan-Shou Zhang — researcher profile on SciRah

Zhen-Zhen Liu×5

Invite

Zhen-Zhen Liu — researcher profile on SciRah

Hong-Jian Yang×5

Invite

Hong-Jian Yang — researcher profile on SciRah

Invite

P. Fu — researcher profile on SciRah

Shu-Sen Wang×5

Invite

Shu-Sen Wang — researcher profile on SciRah

Invite

Beichen Liu — researcher profile on SciRah